5 Marijuana Stocks With Gross Margins Well Above Their Industry Peers
Lorimer Wilson on 2017-06-23 11:47:27.0
Identifying companies with high gross margins in the young marijuana industry is important because operating costs are likely to decrease as the industry matures, leaving these companies with high earnings potential. Today we have identified five Canadian marijuana stocks with gross margins well above their industry peers.
The comments above & below are edited ([ ]) and abridged (?) excerpts from the original articleby SmallCapPower.com
Invictus MD Strategies Corp is a Canada-based company…specializing in acquiring, funding and developing entities which are involved in the medicinal marijuana area. It focuses on the production and distribution of medicinal marijuana through online stores, sale of hydroponic equipment and fertilizers, as well as of accessories for cannabis intake. The Company also is active in research and testing, as well as offers advisory services…
Market Cap: $53,100,643
Total Revenue (LTM): $3,706,130
Debt to Equity: 18.7%
Gross Margin: 35.3%
2. CanniMed Therapeutics Inc. (TSX: CMED) Pharmaceuticals
CanniMed Therapeutics Inc is a Canada-based plant biopharmaceutical company that specializes in the production of pharmaceutical-grade cannabis and offers a range of pharmaceutical-grade cannabis products. In addition, the Company has a plant biotechnology research and product development program focused on the production of plant-based materials for pharmaceutical, agricultural and environmental applications. The Company, through its subsidiary CanniMed Ltd, offers medical cannabis oils, dried medical cannabis, vaporizers, vaporizer parts and accessories. Its CanniMed Oils are made using only dried cannabis flowers.
Market Cap: $182,936,314
Total Revenue (LTM): $5,788,000
Debt to Equity: 127.6%
Gross Margin: 37.1%
3. Canabo Medical Inc. (TSXV: CMM) Healthcare Facilities & Services
Canabo Medical Inc, formerly Four River Ventures Ltd, is a Canada-based company engaged in the provision of medical services and non-cannabinoid products for patients suffering from chronic pain and disabling illnesses… The Company operates 10 medical clinics across Canada. Its medical clinics are operated by qualified health care practitioners, independent medical marijuana evaluations for employers and insurers, and medical marijuana scientific research. Each clinic provides cannabinoid educators, who consult with patients to determine the proper treatment for their ailments using medical marijuana based on the medical documentation as prepared by the physician.
Market Cap: $15,564,609
Total Revenue (LTM): $2,080,850
Debt to Equity: 0.0%
Gross Margin: 53.8%
4. OrganiGram Holdings Inc. (TSXV: OGI) Pharmaceuticals
OrganiGram Holdings Inc., formerly Inform Exploration Corp., is a Canada-based…licensed medical marijuana producer as regulated by Health Canada under the Marijuana Medical Access Regulations (MMAR) of the Government of Canada.
Aphria Inc., formerly Black Sparrow Capital Corp., is a Canada-based company engaged in producing and selling medical marijuana through retail sales and wholesale channels…The Company is also engaged in the research, development and commercial production of cannabis oil.
Market Cap: $736,535,739
Total Revenue (LTM): $8,433,930
Debt to Equity: 0.0%
Gross Margin: 70.9%
Disclosure: Neither the author nor any of the principals at Small Cap Power, or their family members, own shares in any of the companies mentioned above.
Thanks for reading! If you want more articles like the one abovevisit our Facebook page (here) and "Like" any article so you can get future articles automatically delivered to your feed. You can also "Follow the munKNEE" on Twitterorregister to receive ourFREEtri-weekly newsletter (see sample here , sign up in top right hand corner).
Remember: munKNEE should be in everybody's inbox and MONEY in everybody's wallet!
The search is now on for the next junior marijuana stock that is ripe for acquisition. Will it be one of the 5 we've identified based upon their high revenue growth profiles?
The following 5 marijuana stocks are expected to experience anywhere from 188% to 5,338.8% (yes, 5,338.8%!) in revenue growth during the upcoming year.
With intraday fluctuations of up to 80% - yes, 80% - the Canadian marijuana stocks on our list create significant day-trading opportunities for those so inclined.
With operations in the U.S. or a high probability of expanding there, the Canadian marijuana stocks on list are likely going to continue to feel a buzz from the recent U.S. election.
Within the last six years ago, the number of Americans who support legalizing medical marijuana has risen from 70% to 90% according to polls by Quinnipiac and Gallup. Those who support overall legalization has risen from 46% to 54%. Let's explore some of the recent news and changes to the marijuana industry that could impact the industry's growth and accessibility for investors.
A recent United Nations report on drug use reveals drug trends around the world, including which countries have the highest rates of cannabis use. Check out the map.
What is the world's most valuable cash crop? The answer is complicated as it boils down to key factors such as: total amount planted, the rate of yield, and the revenue per unit sold. It also depends on whether we are looking at the absolute value, or the most value per acre. Read on for the answer!
We are of the opinion that the current market for those companies in the marijuana/cannabis sector can be likened to the early days of the high-tech era and, as such, will offer many chances to create wealth in the coming months and years for those who choose to purchase shares in this new investment sector.
Rarely does a new investment sector appear virtually out of the blue, but this is what happened at the beginning of January 2014 as legalization of recreational marijuana in Colorado became a reality giving investors a wealth of opportunities. We have just launched a new online service that provides detailed information on 219 publicly traded companies in the booming industries of cannabis/marijuana research, sales and distribution, as well as the myriad component industries that will accompany.